Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,911.00
+6.60 (0.35%)
May 11, 2026, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 313.76 billion as of May 11, 2026. Its market cap has increased by 31.39% in one year.
Market Cap
313.76B
Enterprise Value
284.77B
Revenue
61.13B
Ranking
n/a
PE Ratio
37.04
Stock Price
1,911.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 313.76B, an increase of 5.61%. That is a compound annual growth rate of 1.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 313.76B | 10.59% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 667.80B |
| Laurus Labs | 663.11B |
| Ipca Laboratories | 393.90B |
| Ajanta Pharma | 379.03B |
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| Piramal Pharma | 238.81B |
| NATCO Pharma | 210.40B |